<DOC>
	<DOCNO>NCT00672659</DOCNO>
	<brief_summary>The primary objective demonstrate whether addition pipamperone 5 mg twice daily ( bd ) citalopram , 40 mg daily patient suffer MDD improve efficacy citalopram 40 mg patient . Secondary objective demonstrate whether addition pipamperone 5 mg twice daily ( bd ) citalopram , 40 mg daily patient suffer MDD : 1 . Will increase rate resolution symptom citalopram 40 mg. 2 . Show combined product safe tolerable . Patients schedule receive study medication eight week final follow-up check carry 28 day complete study . All patient receive active citalopram baseline randomise receive either active pipamperone placebo equivalent eight week time attend 6 study visit .</brief_summary>
	<brief_title>Pipamperone/Citalopram ( PipCit ) Versus Citalopram Treatment Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Pipamperone</mesh_term>
	<criteria>Male female patient 1865 year inclusive Suffering moderate severe MDD define DSM IV existence depress mood loss interest/anhedonia least four week longer six month current episode Diagnosis confirm Mini International Neuropsychiatric Interview ( MINI ) version 5.0.0 . Clinical global impression severity scale ( CGIS ) rating least four minimum Hamilton Depression Scale ( HAMD ) 17 item total score 18 screen baseline A nonpsychotic state Where appropriate , male patient agree use barrier contraceptive measure ( condom ) course study three month last dose medication Premenopausal females use adequate contraceptive measure Considered investigator significant risk suicide score 5 MADRS question 10 Significant psychiatric illness would interfere trial assessment comorbid generalise anxiety disorder ( GAD ) panic disorder permit MDD consider primary diagnosis Significant physical illness would interfere trial assessment Reduced hepatic function Epilepsy History cardiac dysrhythmia Alcohol intake accept UK range Recent ( 1 week ) antidepressant ( except fluoxetine 4 week St John 's Wort MAOI 's 14 day ) , benzodiazepine psychotropic medication ingestion include lithium mood stabiliser Resistant depression define failed respond Two previous antidepressant adequate dose ingest least 4 week current episode To augmentation therapy atypical antipsychotic drug Electroconvulsive therapy ( ECT ) current episode Formal psychotherapy alternative treatment one week prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Lost interest , Depressed Mood</keyword>
</DOC>